We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer (VelGemRad)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01908478
Recruitment Status : Completed
First Posted : July 25, 2013
Last Update Posted : July 15, 2020
Sponsor:
Collaborator:
AbbVie
Information provided by (Responsible Party):
Richard Tuli, MD, Cedars-Sinai Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 14, 2017
Actual Study Completion Date : July 6, 2020